Key result
Only ~20% of Chinese adults with hypertension achieve adequate BP control.
Why the study?
Hypertension prevalence is high and rising in China, but it is inadequately controlled.
Cross-Sectional (n=3,579)
Yes
Hypertension awareness, treatment, and control rates in China remain low (55.7%, 46.5%, and 20.3% respectively), indicating a need for improved screening and management programs.
Answers are grounded in this paper and cite their sources.
Gaps in hypertension care persist in China; leaves open effective strategies for improvement.
Background: Hypertension prevalence is high and rising in China, but it is inadequately controlled. This study investigated hypertension awareness, treatment, and control and their associated factors among Chinese adults. Methods: Data collected from the 2011 China Health and Nutrition Survey (CHNS) from 12,991 Chinese adults were used. Hypertension was defined as systolic blood pressure ≥ 140 mm Hg, diastolic blood pressure ≥ 90 mm Hg, self-reported prior diagnosed hypertension, or taking antihypertensive medications. Hypertension awareness, treatment, and control were defined as a self-reported diagnosis of hypertension, current use of antihypertensive medication, and blood pressure < 140/90 mm Hg, respectively. Multivariate logistic regression was performed to examine factors associated with hypertension awareness, treatment, and control. Results: Overall, 3,579 (27.6%) of the CHNS adult participants had hypertension, of whom 55.7% were aware of their diagnosis, 46.5% were treated with antihypertensive medications, but only 20.3% had their blood pressure controlled. Higher hypertension treatment rate was associated with older age (OR, 2.57; 95%CI, 1.65-4.02), urban residence (1.50; 1.14-1.97), living in the Eastern region (1.52; 1.14-2.01), and having overweight/obesity (1.99; 1.39-2.84); Awareness rate showed the same association as treatment rate with an additional protect factor of being female (1.37, 1.12-1.66). Lower control rate was associated with obesity (0.56; 0.42-0.76) and minority ethnicity (0.52; 0.31-0.86). Conclusion: Hypertension is a major public health burden in China. Rates of hypertension awareness, treatment, and control are still low despite efforts that have been made. More intensive screening and treatment intervention programs are needed in the future.
No takes yet. Share an insight, caveat, or question.
Wei et al. (2020) conducted a cross-sectional in Hypertension (n=3,579). Among Chinese adults with hypertension, 55.7% were aware of their diagnosis, 46.5% were treated with antihypertensive medications, and only 20.3% had their blood pressure controlled.
Synapse has enriched 10 related papers. Consider them for comparative context: